Shanghai Bio-heart Biological Technology Dividends and Buybacks
Dividend criteria checks 0/6
Shanghai Bio-heart Biological Technology does not have a record of paying a dividend.
Key information
n/a
Dividend yield
3.7%
Buyback Yield
| Total Shareholder Yield | 3.7% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth
Nov 15
Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans
Jul 24Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Feb 22Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Nov 03We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth
May 12We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn
Sep 19Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans
Jun 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 2185's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2185's dividend payments have been increasing.
Dividend Yield vs Market
| Shanghai Bio-heart Biological Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2185) | n/a |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Medical Equipment) | 3.3% |
| Analyst forecast (2185) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 2185's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2185's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 2185's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 2185 has not reported any payouts.